{"ticker": {"uuid": "a13e25a6-455c-425d-b512-a5b8d71a2351", "symbol": "688068", "name": "Beijing Hotgen Biotech Co., Ltd.", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "ETFs Investing in Beijing Hotgen Biotech Co. Ltd. Class A Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE1CaHFLOFFSaUFHa3c2RldjLUh4SjRHVm1qNk5yYTR4c21nWUpKR05tclZtTkszWkwwam13MEVLc0JOcUpjYzBTZk40c05qUldYSlZ4RzUtVlVEMU1ablNyZ2pn?oc=5", "source_name": "TradingView", "published_at": "2026-07-21T08:22:24+00:00", "published_display": "21 Jul 2026 08:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coronavirus outbreak pushes Chinese biotech stocks higher despite market downturn", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPeURkOTRSMG1EZHRmOXpiZVhjOWs1WXFzT0oxQjR0VDcyeTI1OWxuNHp0SVVpdUpQSkYtaTFCWjJWbkVFakNHS2FRcTdITTJYeXRJeGdYbVU4anFzNFU4SFl3R1pOTE94M2NRN1kyLVlXX3lkcHM3OC1QSXpQbEprYm5WeGxSbGYwUkhSN1IzXzhHNkNuODhNUjFmNTdqY2FsWTNUc00wSmJKZl9NMVdLdkdNc1ROUnB4VmswZGI5OA?oc=5", "source_name": "BioWorld News", "published_at": "2020-02-06T08:00:00+00:00", "published_display": "06 Feb 2020 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "ETFs Investing in Beijing Hotgen Biotech Co. Ltd. Class A Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE1CaHFLOFFSaUFHa3c2RldjLUh4SjRHVm1qNk5yYTR4c21nWUpKR05tclZtTkszWkwwam13MEVLc0JOcUpjYzBTZk40c05qUldYSlZ4RzUtVlVEMU1ablNyZ2pn?oc=5", "source_name": "TradingView", "published_at": "2026-07-21T08:22:24+00:00", "published_display": "21 Jul 2026 08:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coronavirus outbreak pushes Chinese biotech stocks higher despite market downturn", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPeURkOTRSMG1EZHRmOXpiZVhjOWs1WXFzT0oxQjR0VDcyeTI1OWxuNHp0SVVpdUpQSkYtaTFCWjJWbkVFakNHS2FRcTdITTJYeXRJeGdYbVU4anFzNFU4SFl3R1pOTE94M2NRN1kyLVlXX3lkcHM3OC1QSXpQbEprYm5WeGxSbGYwUkhSN1IzXzhHNkNuODhNUjFmNTdqY2FsWTNUc00wSmJKZl9NMVdLdkdNc1ROUnB4VmswZGI5OA?oc=5", "source_name": "BioWorld News", "published_at": "2020-02-06T08:00:00+00:00", "published_display": "06 Feb 2020 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 58, "total_relevant": 3, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 2, "score": 53, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 2.0, "count": 3}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 127.25, "latest_week": "2026-07-17", "one_week_move": 2.4, "four_week_move": 64.1, "twelve_week_move": 15.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.677945, "market_dynamics_buy_signal": false, "relative_strength": -12.22215, "fair_value_gap": 47.4, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 43.1861, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.4% over one week, +64.1% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 1}, {"label": "Barron's", "count": 1}, {"label": "BioWorld News", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.4% over one week, +64.1% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "ETFs Investing in Beijing Hotgen Biotech Co. Ltd. Class A Stocks"}], "updated_at": "2026-07-22T04:11:17.350810+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}